Azbil BioVigilant announces decision to deploy IMD-A rapid microbial monitoring system by compounding pharmacy innovator
Posted: 8 October 2012 | | No comments yet
Leiter Rx will utilize Azbil BioVigilant’s IMD-A® 300-series systems…
Azbil BioVigilant, Inc., (www.biovigilant.com), inventors of Instantaneous Microbial Detection™, announced today that Leiter Rx, one of the country’s foremost compounding pharmacies, will utilize Azbil BioVigilant’s IMD-A® 300-series systems for select cleanroom applications benefiting from real-time microbial air monitoring.
Leiter Rx, established in 1926, has built a reputation in quality process innovation fundamental to reducing risk of product contamination. Charles Leiter, recognized as one of the leading ophthalmic pharmacists in the country, said, “We have never been afraid to invest in technology that will improve our operations. Azbil BioVigilant’s IMD-A system will be used to continuously monitor our cleanroom during syringe filling operations which will reduce the potential risk of product contamination. We also will utilize the system to promote the best aseptic techniques among our staff. It is a very versatile piece of equipment that keeps us on the cutting edge of quality process advancements.”
When told of the decision, Aric Meares, CEO of Azbil BioVigilant, stated that this was another important milestone for the company. “Pharmaceutical compounding is an area of need where instantaneous microbial detection delivers great benefit. It is gratifying to see Leiter Rx among the first in compounding to utilize our technology platform across their cleanroom area.” He added, “The Food and Drug Administration is actively encouraging drug makers to deploy advanced technologies such as the IMD-A system to realize both quality and drug delivery benefits.”
Azbil BioVigilant’s IMD-A 300 and IMD-A 350 systems can detect immediately the presence of bacteria in the aseptic manufacturing process, and as a result, greatly accelerate the quality assurance processes for drug batch release.